These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6759713)

  • 21. Renal hemodynamics and the renin-angiotensin system in cirrhosis.
    Aliaga L; Zozaya JM; Quiroga J; Richter JA; Prieto J
    Rev Esp Fisiol; 1989; 45 Suppl():371-5. PubMed ID: 2701770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapy of liver cirrhosis. Studies on the hemodynamic effect of xanthinol nicotinate in liver cirrhosis].
    Assheuer J; Boldt I; Schulz D; Winkler C
    Fortschr Med; 1973 Sep; 91(27):1085-8. PubMed ID: 4746762
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of dipyridamole on kidney function in cirrhosis.
    Llach J; Ginès P; Arroyo V; Salmerón JM; Ginès A; Jiménez W; Gaya J; Rivera F; Rodés J
    Hepatology; 1993 Jan; 17(1):59-64. PubMed ID: 8423042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The renin-angiotensin-aldosterone system in liver cirrhosis].
    Chmielewska J
    Przegl Lek; 1983; 40(8):619-22. PubMed ID: 6364257
    [No Abstract]   [Full Text] [Related]  

  • 25. Volume homoeostasis in cirrhosis of the liver. Pathogenetic and therapeutic implications.
    Koomans HA; Van Hattum J; Speelberg B
    Neth J Med; 1986; 29(7):212-20. PubMed ID: 3528875
    [No Abstract]   [Full Text] [Related]  

  • 26. [Interrelationship of liver function and lung hemodynamics in liver cirrhosis].
    Ol'binskaia LI; Antonenko NI
    Sov Med; 1980; (8):12-6. PubMed ID: 7423229
    [No Abstract]   [Full Text] [Related]  

  • 27. Portal and systemic hemodynamics and humoral factors in cirrhosis with and without ascites.
    Hayes PC; Cumming AD; Craig KJ; Watson M; Bouchier IA
    Am J Gastroenterol; 1992 Oct; 87(10):1433-8. PubMed ID: 1415100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Catecholamine and renin-angiotensin system in blood pressure control in patients with liver cirrhosis].
    Bernardi M; Trevisani F; Santini C; Ligabue A; Gasbarrini G
    Boll Soc Ital Biol Sper; 1981 Jun; 57(12):1293-9. PubMed ID: 7028055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of the renin-angiotensin-aldosterone system in cirrhosis with special emphasis on the central blood volume.
    Møller S; Bendtsen F; Henriksen JH
    Scand J Gastroenterol; 2006 Apr; 41(4):451-8. PubMed ID: 16635914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Simultaneous, study of systemic and regional visceral hemodynamics in cirrhosis. 3. Systemic and hepatosplanchnic hemodynamics in decompensated liver cirrhosis, with ascites].
    Greco F; Chiandussi L; Sardi G; Vaccarino A; Curti B; Agostoni A; Zardini P; Toscano G
    Minerva Med; 1967 Feb; 58(11):364-7. PubMed ID: 6019271
    [No Abstract]   [Full Text] [Related]  

  • 31. Verapamil pharmacokinetics and liver function in patients with cirrhosis.
    Finucci GF; Padrini R; Piovan D; Melica E; Merkel C; Gatta A; Zuin R
    Int J Clin Pharmacol Res; 1988; 8(2):123-6. PubMed ID: 3378854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hepatorenal syndrome. Clinical and pathogenetic aspects and therapeutic approach].
    Marmo R; Persico M; Costume A; Bronzino P; Del Vecchio E; Gentile S; Porcellini M
    Clin Ter; 1984 Dec; 111(5):443-9. PubMed ID: 6151436
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatorenal syndrome. A review.
    Altman KA
    Am J Gastroenterol; 1968 May; 49(5):436-9. PubMed ID: 4297522
    [No Abstract]   [Full Text] [Related]  

  • 34. [Role of the renin-angiotensin-aldosterone system in ascitic hepatic cirrhosis. Effects of inhibition of angiotensin I converting enzyme].
    Santucci A; Aguglia F; De Mattia G; Cammarella I; Trinchieri F; Giordano M; Gnecchi M; Ficara C
    Clin Ter; 1983 Jul; 106(2):121-4. PubMed ID: 6313280
    [No Abstract]   [Full Text] [Related]  

  • 35. Circulatory abnormalities in cirrhosis with focus on neurohumoral aspects.
    Møller S; Henriksen JH
    Semin Nephrol; 1997 Nov; 17(6):505-19. PubMed ID: 9353862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis.
    Bosch J; Arroyo V; Betriu A; Mas A; Carrilho F; Rivera F; Navarro-Lopez F; Rodes J
    Gastroenterology; 1980 Jan; 78(1):92-9. PubMed ID: 7350041
    [No Abstract]   [Full Text] [Related]  

  • 37. A1166C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension.
    Sookoian S; Castaño G; García SI; Viudez P; González C; Pirola CJ
    Am J Gastroenterol; 2005 Mar; 100(3):636-42. PubMed ID: 15743363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deranged sodium homeostasis in cirrhosis.
    Epstein M
    Gastroenterology; 1979 Mar; 76(3):622-35. PubMed ID: 428715
    [No Abstract]   [Full Text] [Related]  

  • 39. Renal haemodynamics (GFR, RBF and RPF) in cirrhosis of liver.
    Patnaik SR; Das RK; Sahu H; Choudhury KN; Mahakur AC; Misra SC; Misra D; Patnaik BC
    J Assoc Physicians India; 1983 Sep; 31(9):577-80. PubMed ID: 6668266
    [No Abstract]   [Full Text] [Related]  

  • 40. [Simultaneous study of systemic and regional visceral hemodynamics in cirrhosis. II. Systemic and hepatosplanchnic hemodynamics in compensated alcoholic cirrhosis].
    Greco F; Chiandussi L; Sardi G; Vaccarino A; Agostoni A; Curti B; Toscano G; Zardini P
    Minerva Med; 1967 Feb; 58(11):360-3. PubMed ID: 6019270
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.